Explain this page
Arphra AIPlain-English read on Cytek Biosciences, Inc.’s valuation06-10today
- Cytek Biosciences to participate at the Singular Research's Las Vegas Invitational Conference13d
- Cytek Biosciences to participate at the Singular Research's Las Vegas Invitational Conference13d
- Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 202621d
- Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript47d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $5.13 (+26.04%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.44% | 0.00% | +1.50% | -13.59% | -19.25% | -19.41% | +30.45% | -49.32% | -78.30% | -78.30% | -78.30% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$4.15
8 sh
Bid
$3.46
70 sh
Ask
$4.35
5 sh
Spread
$0.890
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Cytek Biosciences to participate at the Singular Research's Las Vegas Invitational Conferenceglobenewswire.com·Jun 10, 2026
- Cytek Biosciences to participate at the Singular Research's Las Vegas Invitational Conferenceglobenewswire.com·Jun 10, 2026
- Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026globenewswire.com·Jun 02, 2026
- Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcriptseekingalpha.com·May 07, 2026
- Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimateszacks.com·May 07, 2026
- Cytek Biosciences Reports First Quarter 2026 Financial Resultsglobenewswire.com·May 07, 2026
Peers
No peer list available for CTKB.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|